These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 11419985)
21. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686 [TBL] [Abstract][Full Text] [Related]
22. CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma. Vassallo J; Bousquet M; Quelen C; Al Saati T; Delsol G; Brousset P J Clin Pathol; 2007 May; 60(5):573-5. PubMed ID: 17513519 [TBL] [Abstract][Full Text] [Related]
24. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections. Contos MJ; Kornstein MJ; Innes DJ; Ben-Ezra J Mod Pathol; 1992 Nov; 5(6):631-3. PubMed ID: 1285443 [TBL] [Abstract][Full Text] [Related]
25. [Expression of Sox11 transcription factor in different types of B-cell lymphomas]. Zhang WM; Wang C; Li BZ Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):698-9. PubMed ID: 22321551 [No Abstract] [Full Text] [Related]
27. Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphoma. Watson P; Wood KM; Lodge A; McIntosh GG; Milton I; Piggott NH; Proctor SJ; Taylor PR; Smith S; Jack F; Bell H; Steward M; Anderson JJ; Horne CH; Angus B Histopathology; 2000 Feb; 36(2):145-50. PubMed ID: 10672059 [TBL] [Abstract][Full Text] [Related]
28. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719 [TBL] [Abstract][Full Text] [Related]
29. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Dogan A; Bagdi E; Munson P; Isaacson PG Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287 [TBL] [Abstract][Full Text] [Related]
30. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan. Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541 [TBL] [Abstract][Full Text] [Related]
31. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas. Eshoa C; Perkins S; Kampalath B; Shidham V; Juckett M; Chang CC Am J Clin Pathol; 2001 Jun; 115(6):862-7. PubMed ID: 11392883 [TBL] [Abstract][Full Text] [Related]
32. [Gastrointestinal B-cell lymphoma: a morphologic and immunohistochemical study of 194 cases]. He S; Guo Y; Bei CF; Dai YZ; Zhu DB; Li CS; Zhu XH; LE MZ Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):814-8. PubMed ID: 21215096 [TBL] [Abstract][Full Text] [Related]
33. CD5-positive follicular lymphoma: prognostic significance of this aberrant marker? Mayson E; Saverimuttu J; Cartwright K Intern Med J; 2014 Apr; 44(4):417-22. PubMed ID: 24754692 [TBL] [Abstract][Full Text] [Related]
34. Frequent loss of CD10 expression in follicular lymphoma with leukaemic presentation. Chen SW; Chang ST; Hsieh YC; Kuo CC; Wu HC; Feng YH; Chuang SS Malays J Pathol; 2020 Aug; 42(2):237-243. PubMed ID: 32860376 [TBL] [Abstract][Full Text] [Related]
35. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance. Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895 [TBL] [Abstract][Full Text] [Related]
36. Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas. Manazza AD; Bonello L; Pagano M; Chiusa L; Novero D; Stacchini A; Martini G; Vitolo U; Tarella C; Inghirami G; Palestro G; Chiarle R Am J Clin Pathol; 2005 Aug; 124(2):182-90. PubMed ID: 16040287 [TBL] [Abstract][Full Text] [Related]
37. Cutaneous follicle center lymphoma: a clinicopathologic study of 19 cases. Aguilera NS; Tomaszewski MM; Moad JC; Bauer FA; Taubenberger JK; Abbondanzo SL Mod Pathol; 2001 Sep; 14(9):828-35. PubMed ID: 11557777 [TBL] [Abstract][Full Text] [Related]
38. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. Morice WG; Kurtin PJ; Hodnefield JM; Shanafelt TD; Hoyer JD; Remstein ED; Hanson CA Mayo Clin Proc; 2008 Jul; 83(7):776-85. PubMed ID: 18613994 [TBL] [Abstract][Full Text] [Related]
39. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632 [TBL] [Abstract][Full Text] [Related]
40. CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of disease. Sundeen JT; Longo DL; Jaffe ES Am J Surg Pathol; 1992 Feb; 16(2):130-7. PubMed ID: 1370753 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]